IGM Biosciences Inc Working Capital to Net Assets Ratio
IGM Biosciences Inc working capital to net assets ratio. IGM Biosciences Inc (IGMS) has a Working Capital to Net Assets ratio of 100.0% as of June 2025. Working capital of $100.93 Million (current assets of $106.99 Million minus current liabilities of $6.06 Million) is measured against net assets of $100.93 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check IGM Biosciences Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of IGM Biosciences Inc (2017–2024)
Working capital to net assets ratio of IGM Biosciences Inc from 2017 to 2024. This chart shows how IGM Biosciences Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting working capital of $100.93 Million against net assets of $100.93 Million USD. See IGMS days of operational coverage to measure how many days the company can operate on defensive assets alone.
IGM Biosciences Inc Working Capital to Net Assets Ratio by Year (2017–2024)
IGM Biosciences Inc working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for IGM Biosciences Inc from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IGM Biosciences Inc asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 323.8% | $155.98 Million | $48.17 Million | $193.62 Million | $37.64 Million | ▲ +173.7 pp |
| 2023 | 150.1% | $305.12 Million | $203.23 Million | $347.60 Million | $42.48 Million | ▲ +13.1 pp |
| 2022 | 137.1% | $393.74 Million | $287.26 Million | $438.42 Million | $44.69 Million | ▲ +50.1 pp |
| 2021 | 87.0% | $212.97 Million | $244.91 Million | $240.75 Million | $27.78 Million | ▼ -6.3 pp |
| 2020 | 93.2% | $356.03 Million | $381.81 Million | $373.27 Million | $17.24 Million | ▲ +0.7 pp |
| 2019 | 92.5% | $222.22 Million | $240.23 Million | $231.10 Million | $8.88 Million | ▲ +82.7 pp |
| 2018 | 9.8% | $-6.48 Million | $-65.83 Million | $2.41 Million | $8.89 Million | ▲ +9.1 pp |
| 2017 | 0.8% | $-321.00K | $-40.50 Million | $655.00K | $976.00K | — |